Cargando…

Psoriasis and Genetics

Psoriasis is a common inflammatory skin disease caused by the interplay between multiple genetic and environmental risk factors. This review summarises recent progress in elucidating the genetic basis of psoriasis, particularly through large genome-wide association studies. We illustrate the power o...

Descripción completa

Detalles Bibliográficos
Autores principales:	DAND, Nick, MAHIL, Satveer K., CAPON, Francesca, SMITH, Catherine H., SIMPSON, Michael A., BARKER, Jonathan N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128944/ https://www.ncbi.nlm.nih.gov/pubmed/31971603 http://dx.doi.org/10.2340/00015555-3384

Ejemplares similares

Update on psoriasis immunopathogenesis and targeted immunotherapy
por: Mahil, Satveer K., et al.
Publicado: (2015)

Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological Studies
por: Saklatvala, Jake R., et al.
Publicado: (2023)

IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis
por: Catapano, Marika, et al.
Publicado: (2020)

Biomarkers of disease progression in people with psoriasis: a scoping review
por: Ramessur, Ravi, et al.
Publicado: (2022)

The Genetic Basis of Psoriasis
por: Capon, Francesca
Publicado: (2017)

Biomarkers of systemic treatment response in people with psoriasis: a scoping review
por: Corbett, Mark, et al.
Publicado: (2022)

Using Real‐World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic‐Pharmacodynamic Study
por: Pan, Shan, et al.
Publicado: (2020)

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)
por: Mahil, S.K., et al.
Publicado: (2019)

Clinical and genetic differences between pustular psoriasis subtypes
por: Twelves, Sophie, et al.
Publicado: (2019)

The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
por: Liew, Su-Yi, et al.
Publicado: (2022)

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
por: Mahil, Satveer K., et al.
Publicado: (2021)

Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis
por: Bowes, John, et al.
Publicado: (2017)

Psoriasis and other complex trait dermatoses: from loci to functional pathways
por: Capon, Francesca, et al.
Publicado: (2011)

Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling
por: Soomro, Mehreen, et al.
Publicado: (2022)

Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study
por: Wilkinson, Nina, et al.
Publicado: (2019)

Systematic review of deep learning image analyses for the diagnosis and monitoring of skin disease
por: Choy, Shern Ping, et al.
Publicado: (2023)

Vaccine hesitancy and access to psoriasis care during the COVID‐19 pandemic: findings from a global patient‐reported cross‐sectional survey
por: Bechman, Katie, et al.
Publicado: (2022)

Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models
por: Jalali-najafabadi, Farideh, et al.
Publicado: (2021)

A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial
por: Cro, Suzie, et al.
Publicado: (2020)

Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling
por: Dand, Nick, et al.
Publicado: (2017)

Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove
por: Tsakok, Teresa, et al.
Publicado: (2023)

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis
por: Tsakok, Teresa, et al.
Publicado: (2019)

Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
por: Andres-Ejarque, Rosa, et al.
Publicado: (2021)

A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial
por: Cornelius, Victoria, et al.
Publicado: (2018)

Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease
por: Vergnano, Marta, et al.
Publicado: (2020)

Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease
por: Vergnano, Marta, et al.
Publicado: (2021)

Psoriasis
por: Barker, Jonathan
Publicado: (1997)

Network‐Informed Gene Ranking Tackles Genetic Heterogeneity in Exome‐Sequencing Studies of Monogenic Disease
por: Dand, Nick, et al.
Publicado: (2015)

Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
por: Andres-Ejarque, Rosa, et al.
Publicado: (2021)

Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms
por: Warren, RB, et al.
Publicado: (2009)

Genetic susceptibility to psoriasis: an emerging picture
por: Smith, Rhodri Ll, et al.
Publicado: (2009)

Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants
por: Tsoi, Lam C., et al.
Publicado: (2017)

Allele-specific cytokine responses at the HLA-C locus, implications for psoriasis
por: Hundhausen, Christian, et al.
Publicado: (2011)

An In-Depth Characterization of the Major Psoriasis Susceptibility Locus Identifies Candidate Susceptibility Alleles within an HLA-C Enhancer Element
por: Clop, Alex, et al.
Publicado: (2013)

Genetic and Epigenetic Mechanisms of Psoriasis
por: Mateu-Arrom, Laura, et al.
Publicado: (2023)

GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets
por: Dand, Nick, et al.
Publicado: (2023)

Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures
por: Koch, Manja, et al.
Publicado: (2015)

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
por: Mahil, Satveer K, et al.
Publicado: (2021)

Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
por: Prieto-Pérez, Rocío, et al.
Publicado: (2013)

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries
por: Machado, Pedro M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6rs4f3ct0765gc2p7f62t4ceuk